Phase 2 Sy 1425 201 Trial Nct02807558 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase 2 sy 1425 201 trial nct02807558 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase 2 Sy 1425 201 Trial Nct02807558 Today - Breaking & Trending Today

Dr Ball on Prior Research Supporting the SELECT-AML-1 Trial in Newly Diagnosed AML

Brian C. Ball, MD, discusses previous research on tamibarotene in newly diagnosed acute myeloid leukemia, and how these data support the ongoing phase 2 SELECT-AML-1 trial.

....

Division Of Leukemia , Department Of Hematology Hematopoietic Cell Transplantation , Hematopoietic Cell Transplantation , Hematologic Oncology , Onclive Tv , Select Aml 1 , Oral Selective Retinoic Acid Receptor Alpha Inhibitor , Rara Positive Aml , Phase 2 Sy 1425 201 Trial Nct02807558 ,